Angle shares jump on cell harvesting update

Shares in Angle, a specialist medtech company, leapt 20 per cent on Monday after the group said it has extended the operational capability of its Parsortix non-invasive cancer diagnostic product by automating its cell harvesting function.

Shares in Angle, a specialist medtech company, leapt 20 per cent on Monday after the group said it has extended the operational capability of its Parsortix non-invasive cancer diagnostic product by automating its cell harvesting function.

Harvesting is where captured tumour cells are recovered from the Parsortix cassette for molecular analysis.

The company's Founder and Chief Executive, Andrew Newland, said: "We have seen widespread demand from researchers and clinicians for circulating tumour cells to be made available in a test tube after isolation from blood.

"It is testimony to the versatility of our separation technology that we have been able to introduce and automate this capability in such a short time. The consequent prospects for our Parsortix sales are significant."

The Parsortix system's ability to harvest cells for analysis is seen as a major advantage and key competitive differentiator, the group explained. Because of this, top cancer research centres and hospitals currently in discussions with the company have all emphasised the importance of this harvesting capability in meeting a key unmet medical need.

The company added: "The Parsortix system now has the potential to provide users with cancer cells for analysis from a simple blood test - a form of "liquid biopsy". This opens the way for the cells to be analysed to identify the specific mutations of the individual patient's cancer using a wide range of genetic and molecular techniques.

"This then offers the prospect of personalised medicine with drugs and other treatment selected specifically to address the individual patient's own cancer with better patient outcomes and lower costs of treatment."

The share price climbed 21.11% to 54.50p by 15:05 on Monday.

NR

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020

Most Popular

Prepare for the end of the epic bubble in US stocks
US stockmarkets

Prepare for the end of the epic bubble in US stocks

US stocks are as expensive as they’ve ever been. How can you prepare your portfolio for a bubble bursting?
18 Jan 2021
Why we won’t see a house-price crash in 2021
House prices

Why we won’t see a house-price crash in 2021

Lockdown sent house prices berserk as cooped up home-workers fled for bigger properties in the country. And while they won’t rise quite as much this y…
18 Jan 2021
Bitcoin: fool’s gold or the new gold?
Bitcoin

Bitcoin: fool’s gold or the new gold?

With bitcoin hitting new highs last week, and close to becoming a mainstream investment, is it really gold for the 21st century?
15 Jan 2021